These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 2212657)

  • 21. Assessment in mice of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, P. falciparum.
    Etlinger HM; Heimer EP; Trzeciak A; Felix AM; Gillessen D
    Immunology; 1988 Jul; 64(3):551-8. PubMed ID: 3044983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High titer response against a malarial antigen depends on the flanking sequence of the immunizing peptide conjugate.
    Jones GL; Gale J; Lord R; Edmundson HM; Saul A; Pye D
    Pept Res; 1989; 2(4):282-5. PubMed ID: 2520766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of antibody specificity to Plasmodium falciparum merozoite surface protein-1 by adjuvant and MHC haplotype.
    Chang SP; Nikaido CM; Hashimoto AC; Hashiro CQ; Yokota BT; Hui GS
    J Immunol; 1994 Apr; 152(7):3483-90. PubMed ID: 8144929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide.
    Kumar A; Arora R; Kaur P; Chauhan VS; Sharma P
    J Immunol; 1992 Mar; 148(5):1499-505. PubMed ID: 1371529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-titer antisera production using three adjuvants and peptide conjugates derived from malarial surface antigen MSA-2.
    Jones GL; Spencer L; Lord R; Edmundson H; Saul AJ
    Pept Res; 1991; 4(3):138-41. PubMed ID: 1823184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins.
    Zerpa NC; Wide A; Noda J; Bermúdez H; Pabón R; Noya OO
    Exp Parasitol; 2006 Aug; 113(4):227-34. PubMed ID: 16513113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic polypeptides corresponding to the non-repeat regions from the circumsporozoite protein of Plasmodium falciparum: recognition by human T-cells and immunogenicity in owl monkeys.
    López JA; González JM; Kettner A; Arévalo-Herrera M; Herrera S; Corradin G; Roggero MA
    Ann Trop Med Parasitol; 1997 Apr; 91(3):253-65. PubMed ID: 9229019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of a non-repetitive sequence of Plasmodium falciparum circumsporozoite protein in man and mice.
    Del Giudice G; Cheng Q; Mazier D; Berbiguier N; Cooper JA; Engers HD; Chizzolini C; Verdini AS; Bonelli F; Pessi A
    Immunology; 1988 Feb; 63(2):187-91. PubMed ID: 2450833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
    J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A protective merozoite protein of Plasmodium falciparum shares an epitope with surface antigens of Paramecium.
    Sehgal A; Singh NJ; Chakraborty T; Sharma S
    Parasite Immunol; 2004 May; 26(5):219-27. PubMed ID: 15491471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of human T cell response to two Plasmodium falciparum merozoite surface antigens.
    Rzepczyk CM; Ramasamy R; Mutch DA; Ho PC; Battistutta D; Anderson KL; Parkinson D; Doran TJ; Honeyman M
    Eur J Immunol; 1989 Oct; 19(10):1797-802. PubMed ID: 2479561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a tuberculin purified protein derivative--Asn-Ala-Asn-Pro conjugate in bacillus Calmette-Guérin primed mice overcomes H-2 restriction of the antibody response and avoids the need for adjuvants.
    Lussow AR; Del Giudice G; Rénia L; Mazier D; Verhave JP; Verdini AS; Pessi A; Louis JA; Lambert PH
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):2960-4. PubMed ID: 2183219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum.
    Etlinger HM; Felix AM; Gillessen D; Heimer EP; Just M; Pink JR; Sinigaglia F; Stürchler D; Takacs B; Trzeciak A
    J Immunol; 1988 Jan; 140(2):626-33. PubMed ID: 3275719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-mediated immune responses to vaccine peptides derived from the circumsporozoite protein of Plasmodium falciparum.
    Russo DM; Sundy JS; Young JF; Maguire HC; Weidanz WP
    J Immunol; 1989 Jul; 143(2):655-9. PubMed ID: 2472448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VH and VL region structure of antibodies that recognize the (NANP)3 dodecapeptide sequence in the circumsporozoite protein of Plasmodium falciparum.
    Anker R; Zavala F; Pollok BA
    Eur J Immunol; 1990 Dec; 20(12):2757-61. PubMed ID: 2125276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody responses to a synthetic peptide-based malaria vaccine candidate: influence of sequence variants of the peptide.
    Etlinger HM; Renia L; Matile H; Manneberg M; Mazier D; Trzeciak A; Gillessen D
    Eur J Immunol; 1991 Jun; 21(6):1505-11. PubMed ID: 2044658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC).
    Udhayakumar V; Saekhou A; Fang S; Jue D; Wohlhueter RM; Lal AA
    Vaccine; 1998; 16(9-10):982-8. PubMed ID: 9682348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral immune responses to Plasmodium falciparum antigens in children and adults living in a hypoendemic area of Punjab (Pakistan).
    Iqbal J; Rab A; Perlmann P; Berzins K
    Am J Trop Med Hyg; 1994 Oct; 51(4):444-53. PubMed ID: 7943571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.